Apolipoproteins are lipid binding proteins involved in the transport of cholesterol, triglycerides and phospholipids in the plasma. Defects in the structure or biosynthesis of these proteins may result in disorders of the plasma lipid transport system and the development of premature coronary artery disease. We have recently shown that the genes coding for three apolipoproteins - namely, AI (apoAI), CIII (apoCIII) and AIV (apoAIV) - are clustered within a 15 kilobase DNA segment on the long arm of human chromosome 11. We have also shown that the haplotypes of eleven restriction site polymorphisms located within and near this gene cluster comprise a highly informative marker for genetic and epidemiological studies. A long term comprehensive characterization of possible mutations in the apoAI, apoCIII and apoAIV genes resulting in dyslipoproteinemias and the development of premature coronary artery disease, requires both the identification of specific haplotypes cosegregating and associated with these disorders, and the availability of gene expression systems in which the function of the genes represented by these haplotypes can be evaluated. We therefore propose to use the polymorphisms in this apolipoprotein gene cluster for genetic linkage between segregating haplotypes and familial high density lipoprotein deficiency (hypoalphalipoproteinemia), and for association of specific haplotypes with premature coronary artery disease and hypoalphalipoproteinemia. In parallel, we will continue with the development of gene expression systems in which the specific transcription, pre-mRNA splicing, translation and regulation of expression by cis- and trans-acting factors of all three cloned apoAI, apoCIII, and apoAIV genes, can be evaluated. We will use these expression systems for the study of apoAI, apoCIII and apoAIV genes representing specific haplotypes that co-segregate with hypoalphalipoproteinemia and haplotypes associated with premature coronary artery disease and hypoalphalipoproteinemia. Discovery and detailed structural and functional characterization of mutations within or near the apoAI, apoCIII, and apoAIV genes resulting in hypoalphalipoproteinemia and premature coronary artery disease, will facilitate both further understanding of mechanisms by which the function of a gene may be impaired and the development of genetic tests by which early diagnosis and treatment of these disorders may be accomplished.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL032032-06
Application #
3343247
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1987-07-01
Project End
1992-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Ginsburg, G S; Ozer, J; Karathanasis, S K (1995) Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4. J Clin Invest 96:528-38
Mietus-Snyder, M; Sladek, F M; Ginsburg, G S et al. (1992) Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells. Mol Cell Biol 12:1708-18
Widom, R L; Rhee, M; Karathanasis, S K (1992) Repression by ARP-1 sensitizes apolipoprotein AI gene responsiveness to RXR alpha and retinoic acid. Mol Cell Biol 12:3380-9
Lamon-Fava, S; Sastry, R; Ferrari, S et al. (1992) Evolutionary distinct mechanisms regulate apolipoprotein A-I gene expression: differences between avian and mammalian apoA-I gene transcription control regions. J Lipid Res 33:831-42
Widom, R L; Ladias, J A; Kouidou, S et al. (1991) Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells. Mol Cell Biol 11:677-87
Rottman, J N; Widom, R L; Nadal-Ginard, B et al. (1991) A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways. Mol Cell Biol 11:3814-20
Antonarakis, S E; Oettgen, P; Chakravarti, A et al. (1988) DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster. Hum Genet 80:265-73
Sastry, K N; Seedorf, U; Karathanasis, S K (1988) Different cis-acting DNA elements control expression of the human apolipoprotein AI gene in different cell types. Mol Cell Biol 8:605-14
Karathanasis, S K; Ferris, E; Haddad, I A (1987) DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci U S A 84:7198-202
Haddad, I A; Ordovas, J M; Fitzpatrick, T et al. (1986) Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes. J Biol Chem 261:13268-77

Showing the most recent 10 out of 17 publications